Editas Medicine, Inc. (EDIT) stock
EDITNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3035% above fair value
$2.14−0.24 (-10.08%)
Close on Nov 12, 2026Market cap $328.66MP/E –Yield –
Editas Medicine market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Editas Medicine's market cap was $232.92M on Nov 11, 2026, against $224.77M a year earlier. Over the last 5 years it ranged from $95.97M to $1.81B, with a median of $427.62M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $232.92M | +21.8% |
| 2025 | Dec 31, 2025 | $191.19M | +82.4% |
| 2024 | Dec 31, 2024 | $104.82M | -87.3% |
| 2023 | Dec 29, 2023 | $827.30M | +35.6% |
| 2022 | Dec 30, 2022 | $609.92M | -66.4% |
| 2021 | Dec 31, 2021 | $1.81B | -58.4% |
| 2020 | Dec 31, 2020 | $4.36B | +188.3% |
| 2019 | Dec 31, 2019 | $1.51B | +39.9% |
| 2018 | Dec 31, 2018 | $1.08B | -15.9% |
| 2017 | Dec 29, 2017 | $1.29B | +122.5% |
| 2016 | Dec 30, 2016 | $577.93M | – |
See a number that looks wrong?